Atlas Trials

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Clinical trial NCT04234048 · RECRUITING

Trial details

NCT number
NCT04234048
Sponsor
SciTech Development, Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell LymphomaPeripheral T-Cell Lymphoma, Not ClassifiedPrimary Cutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, UnspecifiedCutaneous T-cell LymphomaFollicular T-Cell LymphomaAngioimmunoblastic T-cell LymphomaSézary's DiseaseMycosis Fungoides
Start date
2023-12-18
Primary completion
2026-12-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.